nodes	percent_of_prediction	percent_of_DWPC	metapath
Rasagiline—BCL2—C-MYB transcription factor network—SLC25A3—salivary gland cancer	0.0459	0.0516	CbGpPWpGaD
Rasagiline—BCL2—Caspase Cascade in Apoptosis—GAS2—salivary gland cancer	0.0434	0.0488	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—ALKBH1—salivary gland cancer	0.0379	0.0426	CbGpPWpGaD
Rasagiline—BCL2—IL2 signaling events mediated by PI3K—MYB—salivary gland cancer	0.0257	0.0289	CbGpPWpGaD
Rasagiline—BCL2—neck—salivary gland cancer	0.0256	0.232	CbGeAlD
Rasagiline—BCL2—FAS pathway and Stress induction of HSP regulation—PRKDC—salivary gland cancer	0.0241	0.0271	CbGpPWpGaD
Rasagiline—BCL2—Validated targets of C-MYC transcriptional repression—ITGB4—salivary gland cancer	0.0226	0.0254	CbGpPWpGaD
Rasagiline—BCL2—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—CYLD—salivary gland cancer	0.0219	0.0246	CbGpPWpGaD
Rasagiline—BCL2—Corticotropin-releasing hormone—KRT14—salivary gland cancer	0.0208	0.0234	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—GAS2—salivary gland cancer	0.0195	0.0219	CbGpPWpGaD
Rasagiline—BCL2—C-MYB transcription factor network—SMARCA2—salivary gland cancer	0.0191	0.0214	CbGpPWpGaD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—WNT5B—salivary gland cancer	0.0188	0.0212	CbGpPWpGaD
Rasagiline—BCL2—TP53 Network—ATM—salivary gland cancer	0.0186	0.0209	CbGpPWpGaD
Rasagiline—BCL2—connective tissue—salivary gland cancer	0.0183	0.167	CbGeAlD
Rasagiline—BCL2—epithelium—salivary gland cancer	0.0174	0.158	CbGeAlD
Rasagiline—BCL2—Apoptosis—HIST1H1E—salivary gland cancer	0.0162	0.0181	CbGpPWpGaD
Rasagiline—BCL2—IL2 signaling events mediated by PI3K—FOXO3—salivary gland cancer	0.0156	0.0175	CbGpPWpGaD
Rasagiline—BCL2—IL-5 Signaling Pathway—FOXO3—salivary gland cancer	0.0147	0.0165	CbGpPWpGaD
Rasagiline—BCL2—IL-2 Signaling Pathway—FOXO3—salivary gland cancer	0.0141	0.0158	CbGpPWpGaD
Rasagiline—BCL2—Integrated Cancer Pathway—BRCA1—salivary gland cancer	0.0141	0.0158	CbGpPWpGaD
Rasagiline—BCL2—lymphoid tissue—salivary gland cancer	0.0134	0.122	CbGeAlD
Rasagiline—BCL2—C-MYB transcription factor network—MYB—salivary gland cancer	0.0133	0.015	CbGpPWpGaD
Rasagiline—BCL2—Amyotrophic lateral sclerosis (ALS)—MAP2K2—salivary gland cancer	0.0125	0.014	CbGpPWpGaD
Rasagiline—BCL2—Signaling events mediated by Stem cell factor receptor (c-Kit)—FOXO3—salivary gland cancer	0.0121	0.0136	CbGpPWpGaD
Rasagiline—BCL2—IL-5 Signaling Pathway—MAP2K2—salivary gland cancer	0.012	0.0135	CbGpPWpGaD
Rasagiline—BCL2—IL-2 Signaling Pathway—MAP2K2—salivary gland cancer	0.0115	0.0129	CbGpPWpGaD
Rasagiline—BCL2—ATF-2 transcription factor network—BRCA1—salivary gland cancer	0.0111	0.0125	CbGpPWpGaD
Rasagiline—BCL2—Interleukin-11 Signaling Pathway—MAP2K2—salivary gland cancer	0.0111	0.0125	CbGpPWpGaD
Rasagiline—BCL2—Kit receptor signaling pathway—FOXO3—salivary gland cancer	0.0107	0.0121	CbGpPWpGaD
Rasagiline—BCL2—Validated targets of C-MYC transcriptional repression—BRCA1—salivary gland cancer	0.0106	0.0119	CbGpPWpGaD
Rasagiline—BCL2—Ceramide signaling pathway—MAP2K2—salivary gland cancer	0.0103	0.0116	CbGpPWpGaD
Rasagiline—BCL2—Validated targets of C-MYC transcriptional repression—FOXO3—salivary gland cancer	0.0102	0.0115	CbGpPWpGaD
Rasagiline—BCL2—Signaling events mediated by Stem cell factor receptor (c-Kit)—MAP2K2—salivary gland cancer	0.00986	0.0111	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—DAPK1—salivary gland cancer	0.00952	0.0107	CbGpPWpGaD
Rasagiline—BCL2—Integrated Cancer Pathway—ATM—salivary gland cancer	0.00948	0.0107	CbGpPWpGaD
Rasagiline—BCL2—IL2-mediated signaling events—MAP2K2—salivary gland cancer	0.00942	0.0106	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—ITGB4—salivary gland cancer	0.00933	0.0105	CbGpPWpGaD
Rasagiline—BCL2—Kit receptor signaling pathway—MAP2K2—salivary gland cancer	0.00877	0.00986	CbGpPWpGaD
Rasagiline—MAOB—parotid gland—salivary gland cancer	0.00868	0.0788	CbGeAlD
Rasagiline—BCL2—Direct p53 effectors—VCAN—salivary gland cancer	0.00835	0.00938	CbGpPWpGaD
Rasagiline—MAOB—saliva-secreting gland—salivary gland cancer	0.00831	0.0755	CbGeAlD
Rasagiline—BCL2—TP53 Network—TP53—salivary gland cancer	0.00786	0.00884	CbGpPWpGaD
Rasagiline—MAOB—connective tissue—salivary gland cancer	0.00764	0.0694	CbGeAlD
Rasagiline—BCL2—lymph node—salivary gland cancer	0.00757	0.0687	CbGeAlD
Rasagiline—BCL2—Signaling events mediated by Stem cell factor receptor (c-Kit)—CREBBP—salivary gland cancer	0.00732	0.00823	CbGpPWpGaD
Rasagiline—BCL2—Role of Calcineurin-dependent NFAT signaling in lymphocytes—CREBBP—salivary gland cancer	0.00699	0.00786	CbGpPWpGaD
Rasagiline—BCL2—Estrogen signaling pathway—PIK3CA—salivary gland cancer	0.00698	0.00784	CbGpPWpGaD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—FOXO3—salivary gland cancer	0.00657	0.00739	CbGpPWpGaD
Rasagiline—BCL2—Activation of BH3-only proteins—TP53—salivary gland cancer	0.00631	0.00709	CbGpPWpGaD
Rasagiline—BCL2—Integrated Cancer Pathway—PTEN—salivary gland cancer	0.00588	0.00661	CbGpPWpGaD
Rasagiline—BCL2—IL2 signaling events mediated by STAT5—PIK3CA—salivary gland cancer	0.00564	0.00634	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—TOP2A—salivary gland cancer	0.00544	0.00611	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—BRCA1—salivary gland cancer	0.00525	0.0059	CbGpPWpGaD
Rasagiline—BCL2—Signaling events mediated by Stem cell factor receptor (c-Kit)—PTEN—salivary gland cancer	0.00523	0.00588	CbGpPWpGaD
Rasagiline—BCL2—EPO signaling pathway—HRAS—salivary gland cancer	0.00496	0.00557	CbGpPWpGaD
Rasagiline—BCL2—C-MYB transcription factor network—CREBBP—salivary gland cancer	0.00491	0.00552	CbGpPWpGaD
Rasagiline—BCL2—ATF-2 transcription factor network—CCND1—salivary gland cancer	0.00482	0.00542	CbGpPWpGaD
Rasagiline—BCL2—IL2 signaling events mediated by PI3K—PIK3CA—salivary gland cancer	0.00477	0.00536	CbGpPWpGaD
Rasagiline—BCL2—Role of Calcineurin-dependent NFAT signaling in lymphocytes—EP300—salivary gland cancer	0.00476	0.00535	CbGpPWpGaD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—ATM—salivary gland cancer	0.00459	0.00516	CbGpPWpGaD
Rasagiline—BCL2—Validated targets of C-MYC transcriptional repression—CCND1—salivary gland cancer	0.00458	0.00514	CbGpPWpGaD
Rasagiline—BCL2—Intrinsic Pathway for Apoptosis—TP53—salivary gland cancer	0.00452	0.00507	CbGpPWpGaD
Rasagiline—BCL2—Amyotrophic lateral sclerosis (ALS)—TP53—salivary gland cancer	0.00452	0.00507	CbGpPWpGaD
Rasagiline—BCL2—Kit receptor signaling pathway—EP300—salivary gland cancer	0.00444	0.00499	CbGpPWpGaD
Rasagiline—BCL2—ATF-2 transcription factor network—EP300—salivary gland cancer	0.00444	0.00499	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—BRCA1—salivary gland cancer	0.00435	0.00489	CbGpPWpGaD
Rasagiline—BCL2—Validated targets of C-MYC transcriptional repression—EP300—salivary gland cancer	0.00421	0.00473	CbGpPWpGaD
Rasagiline—BCL2—Integrated Cancer Pathway—TP53—salivary gland cancer	0.00402	0.00451	CbGpPWpGaD
Rasagiline—BCL2—IL-2 Signaling Pathway—HRAS—salivary gland cancer	0.00399	0.00448	CbGpPWpGaD
Rasagiline—BCL2—Interleukin-11 Signaling Pathway—HRAS—salivary gland cancer	0.00384	0.00432	CbGpPWpGaD
Rasagiline—BCL2—Signaling events mediated by Stem cell factor receptor (c-Kit)—PIK3CA—salivary gland cancer	0.00369	0.00415	CbGpPWpGaD
Rasagiline—BCL2—C-MYB transcription factor network—CCND1—salivary gland cancer	0.00363	0.00408	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—ATM—salivary gland cancer	0.00354	0.00397	CbGpPWpGaD
Rasagiline—BCL2—IL2-mediated signaling events—PIK3CA—salivary gland cancer	0.00352	0.00396	CbGpPWpGaD
Rasagiline—BCL2—IL-3 Signaling Pathway—HRAS—salivary gland cancer	0.00352	0.00396	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—MAP2K2—salivary gland cancer	0.00344	0.00387	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—DTX4—salivary gland cancer	0.00342	0.00384	CbGpPWpGaD
Rasagiline—BCL2—Signaling events mediated by Stem cell factor receptor (c-Kit)—HRAS—salivary gland cancer	0.00341	0.00384	CbGpPWpGaD
Rasagiline—BCL2—C-MYB transcription factor network—EP300—salivary gland cancer	0.00335	0.00376	CbGpPWpGaD
Rasagiline—BCL2—Direct p53 effectors—CREBBP—salivary gland cancer	0.00326	0.00367	CbGpPWpGaD
Rasagiline—BCL2—IL2-mediated signaling events—HRAS—salivary gland cancer	0.00326	0.00366	CbGpPWpGaD
Rasagiline—MAOB—lymph node—salivary gland cancer	0.00315	0.0286	CbGeAlD
Rasagiline—BCL2—Innate Immune System—CYLD—salivary gland cancer	0.00309	0.00347	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—CDH1—salivary gland cancer	0.00305	0.00343	CbGpPWpGaD
Rasagiline—BCL2—Kit receptor signaling pathway—HRAS—salivary gland cancer	0.00304	0.00341	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—CDH1—salivary gland cancer	0.00299	0.00336	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—PRKDC—salivary gland cancer	0.00296	0.00333	CbGpPWpGaD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—CCND1—salivary gland cancer	0.00295	0.00332	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—ISYNA1—salivary gland cancer	0.00294	0.0033	CbGpPWpGaD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—PTEN—salivary gland cancer	0.00293	0.0033	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—ATM—salivary gland cancer	0.00293	0.00329	CbGpPWpGaD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—PTEN—salivary gland cancer	0.00285	0.0032	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—FGF16—salivary gland cancer	0.00283	0.00318	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—CREBBP—salivary gland cancer	0.00255	0.00286	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—TP53—salivary gland cancer	0.00239	0.00269	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—MARCKS—salivary gland cancer	0.00239	0.00269	CbGpPWpGaD
Rasagiline—BCL2—Direct p53 effectors—PTEN—salivary gland cancer	0.00233	0.00262	CbGpPWpGaD
Rasagiline—BCL2—C-MYB transcription factor network—HRAS—salivary gland cancer	0.00229	0.00257	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—CCND1—salivary gland cancer	0.00227	0.00255	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis Modulation and Signaling—TP53—salivary gland cancer	0.00225	0.00252	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PYGB—salivary gland cancer	0.00222	0.0025	CbGpPWpGaD
Rasagiline—BCL2—Direct p53 effectors—EP300—salivary gland cancer	0.00222	0.0025	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—PTEN—salivary gland cancer	0.00219	0.00247	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—EP300—salivary gland cancer	0.00209	0.00235	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—FGFR4—salivary gland cancer	0.00209	0.00235	CbGpPWpGaD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—PIK3CA—salivary gland cancer	0.00201	0.00226	CbGpPWpGaD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—TP53—salivary gland cancer	0.002	0.00225	CbGpPWpGaD
Rasagiline—BCL2—Immune System—DTX4—salivary gland cancer	0.00199	0.00224	CbGpPWpGaD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—TP53—salivary gland cancer	0.00194	0.00218	CbGpPWpGaD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—HRAS—salivary gland cancer	0.00192	0.00215	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—CCND1—salivary gland cancer	0.00189	0.00213	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—CCND1—salivary gland cancer	0.00188	0.00212	CbGpPWpGaD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—HRAS—salivary gland cancer	0.00186	0.00209	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—PTEN—salivary gland cancer	0.00183	0.00205	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—PTEN—salivary gland cancer	0.00182	0.00204	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PHGDH—salivary gland cancer	0.00181	0.00204	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CYLD—salivary gland cancer	0.0018	0.00202	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—ST3GAL4—salivary gland cancer	0.00175	0.00196	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—EP300—salivary gland cancer	0.00173	0.00195	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—FOXO3—salivary gland cancer	0.00173	0.00195	CbGpPWpGaD
Rasagiline—BCL2—Immune System—PRKDC—salivary gland cancer	0.00173	0.00194	CbGpPWpGaD
Rasagiline—BCL2—Immune System—FGF16—salivary gland cancer	0.00165	0.00185	CbGpPWpGaD
Rasagiline—BCL2—Direct p53 effectors—TP53—salivary gland cancer	0.00159	0.00179	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—AQP1—salivary gland cancer	0.00158	0.00178	CbGpPWpGaD
Rasagiline—BCL2—Immune System—NUP62—salivary gland cancer	0.00158	0.00177	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—TP53—salivary gland cancer	0.0015	0.00168	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—TP53—salivary gland cancer	0.00147	0.00165	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—MAP2K2—salivary gland cancer	0.00142	0.00159	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—salivary gland cancer	0.00129	0.00145	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—EP300—salivary gland cancer	0.00129	0.00145	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—PIK3CA—salivary gland cancer	0.00129	0.00145	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—PIK3CA—salivary gland cancer	0.00128	0.00144	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—NUP62—salivary gland cancer	0.00126	0.00141	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—VCAN—salivary gland cancer	0.00125	0.0014	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—TP53—salivary gland cancer	0.00124	0.00139	CbGpPWpGaD
Rasagiline—BCL2—Immune System—FGFR4—salivary gland cancer	0.00122	0.00137	CbGpPWpGaD
Rasagiline—BCL2—Immune System—FBXW7—salivary gland cancer	0.0012	0.00134	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—HRAS—salivary gland cancer	0.00119	0.00134	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—CREBBP—salivary gland cancer	0.00105	0.00118	CbGpPWpGaD
Rasagiline—BCL2—Immune System—FOXO3—salivary gland cancer	0.00101	0.00113	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—salivary gland cancer	0.000883	0.000992	CbGpPWpGaD
Rasagiline—BCL2—Immune System—MAP2K2—salivary gland cancer	0.000824	0.000926	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—PTEN—salivary gland cancer	0.000751	0.000844	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—EP300—salivary gland cancer	0.000716	0.000805	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—ISYNA1—salivary gland cancer	0.000679	0.000763	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CREBBP—salivary gland cancer	0.000612	0.000688	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CDH1—salivary gland cancer	0.000608	0.000683	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—MARCKS—salivary gland cancer	0.000554	0.000622	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—PIK3CA—salivary gland cancer	0.00053	0.000595	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PYGB—salivary gland cancer	0.000515	0.000578	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—HRAS—salivary gland cancer	0.00049	0.000551	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—CREBBP—salivary gland cancer	0.000487	0.000548	CbGpPWpGaD
Rasagiline—BCL2—Immune System—PTEN—salivary gland cancer	0.000437	0.000491	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PHGDH—salivary gland cancer	0.00042	0.000472	CbGpPWpGaD
Rasagiline—BCL2—Immune System—EP300—salivary gland cancer	0.000417	0.000469	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—ST3GAL4—salivary gland cancer	0.000404	0.000454	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—AQP1—salivary gland cancer	0.000367	0.000412	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PTEN—salivary gland cancer	0.000348	0.000391	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—EP300—salivary gland cancer	0.000332	0.000373	CbGpPWpGaD
Rasagiline—BCL2—Immune System—PIK3CA—salivary gland cancer	0.000309	0.000347	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—NUP62—salivary gland cancer	0.000291	0.000327	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—VCAN—salivary gland cancer	0.000289	0.000324	CbGpPWpGaD
Rasagiline—BCL2—Immune System—HRAS—salivary gland cancer	0.000285	0.000321	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.000253	0.000285	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PIK3CA—salivary gland cancer	0.000246	0.000276	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	0.000181	0.000203	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	0.000172	0.000194	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	0.000128	0.000143	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—CREBBP—salivary gland cancer	0.000113	0.000127	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PTEN—salivary gland cancer	8.06e-05	9.05e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—EP300—salivary gland cancer	7.68e-05	8.63e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PIK3CA—salivary gland cancer	5.68e-05	6.39e-05	CbGpPWpGaD
